CSIMarket
 


Sophiris Bio Inc.  (SPHS)
Other Ticker:  
 
 

SPHS's EPS from Cont. Operations Growth by Quarter and Year

Sophiris Bio's EPS from Cont. Operations results by quarter and year




SPHS EPS from Cont. Operations (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.18 -0.13 -0.02
III Quarter September -0.03 -0.10 -0.09 -0.17
II Quarter June -0.07 -0.20 0.02 -0.21
I Quarter March -0.08 -0.11 -0.09 -0.13
FY   -0.18 -0.23 -0.29 -0.53



SPHS EPS from Cont. Operations third quarter 2019 Y/Y Growth Comment
Sophiris Bio Inc. in the third quarter 2019 recorded EPS loss from Cont. Operations of $ -0.03 .

According to the results reported in the third quarter 2019, Sophiris Bio Inc. achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Sophiris Bio Inc.' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2019.




SPHS EPS from Cont. Operations ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Sophiris Bio's third quarter 2019 EPS from Cont. Operations $ -0.03 SPHS's Income Statement
Sophiris Bio's third quarter 2018 EPS from Cont. Operations $ -0.10 Quarterly SPHS's Income Statement
New: More SPHS's historic EPS from Cont. Operations Growth >>


SPHS EPS from Cont. Operations (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Sophiris Bio's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SPHS's III. Quarter Q/Q EPS from Cont. Operations Comment
Although Sophiris Bio Inc. in the III. Quarter 2019 admitted EPS loss from Cont. Operations of $ -0.03 , management point out, that those numbers show slight up side relative to the -0.07 in the second quarter.

Within Major Pharmaceutical Preparations industry Sophiris Bio Inc. achieved highest sequential EPS from Cont. Operations growth. While Sophiris Bio's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SPHS's III. Quarter Q/Q EPS from Cont. Operations Comment
Even if Sophiris Bio Inc. in the III. Quarter 2019 admitted EPS loss from Cont. Operations of $ -0.03 , it should be point out, that this point to slight up side in contrast to the -0.07 in the second quarter.

Within Major Pharmaceutical Preparations industry Sophiris Bio Inc. achieved highest sequential EPS from Cont. Operations growth. While Sophiris Bio's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Sophiris Bio's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.00 $ -0.07 $ -0.20 $ -0.23 $ -0.54
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Sophiris Bio Inc. achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Sophiris Bio Inc. achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
SPHS's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for SPHS's Competitors
EPS from Cont. Operations Growth for Sophiris Bio's Suppliers
EPS from Cont. Operations Growth for SPHS's Customers

You may also want to know
SPHS's Annual Growth Rates SPHS's Profitability Ratios SPHS's Asset Turnover Ratio SPHS's Dividend Growth
SPHS's Roe SPHS's Valuation Ratios SPHS's Financial Strength Ratios SPHS's Dividend Payout Ratio
SPHS's Roa SPHS's Inventory Turnover Ratio SPHS's Growth Rates SPHS's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2019
Iqvia Holdings Inc -3.33%$ -3.333 
Select Medical Holdings Corp-4.17%$ -4.167 
Dexcom Inc -5.66%$ -5.660 
Acadia Healthcare Company Inc -7.55%$ -7.547 
National Healthcare Corp-8.63%$ -8.633 
Pro dex Inc -9.68%$ -9.677 
Nature s Sunshine Products inc -12.50%$ -12.500 
Innoviva Inc -17.02%$ -17.021 
Bio techne Corp-17.39%$ -17.391 
Hca Healthcare Inc -18.18%$ -18.182 
Luna Innovations Inc-20.00%$ -20.000 
Stryker Corp-21.52%$ -21.519 
Magellan Health inc -21.62%$ -21.622 
Revvity Inc -22.06%$ -22.059 
Exelixis Inc -23.81%$ -23.810 
Zynex inc -25.00%$ -25.000 
Meridian Bioscience Inc -25.09%$ -25.092 
Ani Pharmaceuticals Inc-25.58%$ -25.581 
Jazz Pharmaceuticals Plc-27.13%$ -27.126 
Laboratory Corporation Of America Holdings-28.03%$ -28.025 
Bristol myers Squibb Company-28.45%$ -28.448 
Healthcare Services Group Inc -28.57%$ -28.571 
Baxter International Inc -29.41%$ -29.412 
Abbvie inc -29.83%$ -29.834 
Nuvasive Inc-32.26%$ -32.258 
Horizon Therapeutics Public Limited Company-37.50%$ -37.500 
Amphastar Pharmaceuticals Inc -40.00%$ -40.000 
Radnet Inc -40.00%$ -40.000 
Universal Health Services Inc -40.54%$ -40.541 
Utah Medical Products Inc-44.75%$ -44.751 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com